DocDollars

Purdue Pharma L.P.

CT · United States · Reporting entity ID 100000005432

Total reported 2019–2025
$38.8M
#201 of 2,960 reporting companies — 0% of all reported industry payments
$21.0M in general payments across 1,090 records, plus $17.8M in research funding across 864 records.

How it breaks down

General payments $20,989,579
Research funding $17,762,598

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Purdue Pharma L.P. reported $38.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #201 of 2,960 reporting companies. 46% of that was research funding and 54% general payments such as consulting, speaking, food and travel. 1,090 general payment records and 864 research records were filed.

Common questions about Purdue Pharma L.P.

How much has Purdue Pharma L.P. paid US doctors?

Purdue Pharma L.P. reported $38,752,177 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $20,989,579 in general payments, $17,762,598 in research funding.

How does Purdue Pharma L.P. rank among drug and device companies?

It ranks #201 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Purdue Pharma L.P. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.